Powered by Business Wire
Search Results for Topix.net

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of InterMune, Inc. In Connection With The Proposed Sale Of The Company To Roche Holdings, Inc.

STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of InterMune, Inc. (“InterMune” or the “Company”) (NASDAQ: ITMN) relating to the proposed buyout of the Company by Roche Holdings, Inc. (“Roche”).

On August 24, 2014, InterMune and Roche announced the signing of a definitive merger agreement pursuant to which Roche will acquire InterMune in a transaction valued at approximately $8.3 billion. Under the terms of the transaction, InterMune shareholders are anticipated to receive $74.00 in cash for each share of InterMune common stock they own.

The firm’s investigation seeks to determine, among other things, whether the Company’s Board of Directors breached their fiduciary duties by failing to maximize shareholder value before agreeing to enter into the transaction, and whether Roche is underpaying for InterMune shares.

If you currently own common stock of InterMune and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.


Brower Piven, A Professional Corporation
Charles J. Piven, 410-415-6616
1925 Old Valley Road
Stevenson, Maryland 21153